Skip to content

Clinical observations on the treatment of moderate-to-severe atopic dermatitis and its comorbidities with Upadacitinib

Clinical observations on the treatment of moderate-to-severe atopic dermatitis and its comorbidities with Upadacitinib

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400080649
Enrollment
Unknown
Registered
2024-02-04
Start date
2024-02-05
Completion date
Unknown
Last updated
2024-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Moderate to severe atopic dermatitis and its complications

Interventions

Moderate to severe atopic dermatitis combined with chronic spontaneous urticaria group/Moderate to severe atopic dermatitis combined with non-specific eczema group/Moderate to severe atopic dermatitis

Sponsors

The First Affiliated Hospital of Soochow University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Age = 18 years old; (2) Meets the diagnostic criteria for Zhang's AD in China; (3) Eczema Area and Severity Index (EASI) = 24; (4) Meets the diagnostic criteria for chronic spontaneous urticaria/non atopic eczema/vitiligo; (5) Traditional treatments, including topical corticosteroids (TCS), calcineurin inhibitors (TCI), phosphodiesterase 4 (PDE-4) inhibitors, oral antihistamines, etc., did not reduce or even increase the eczema area and severity index (EASI) score.

Exclusion criteria

Exclusion criteria: (1) Other itchy diseases or skin diseases with clinical phenotypes similar to AD, such as scabies, bullous pemphigoid, skin T-cell lymphoma, contact dermatitis, psoriasis, and drug rash; (2) Individuals at risk of worm infection; (3) Previously used JAK inhibitors or other systemic immunosuppressive treatments. All patients or guardians have signed informed consent forms for follow-up.

Design outcomes

Primary

MeasureTime frame
EASI Score;NRS;VASI;

Countries

China

Contacts

Public ContactMin Wei

The First Affiliated Hospital of Soochow University

minwei@suda.edu.cn+86 18 994 439 4216

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026